Virtu Financial’s CervoMed CRVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$75K Buy
+24,093
New +$84.9K ﹤0.01% 1157
2025
Q1
Sell
-11,224
Closed -$26K 1473
2024
Q4
$26K Buy
+11,224
New +$109K ﹤0.01% 1257
2022
Q1
Sell
-2,017
Closed -$46K 1590
2021
Q4
$46K Buy
+2,017
New +$63.1K ﹤0.01% 1362
2021
Q3
Sell
-3,808
Closed -$209K 1582
2021
Q2
$209K Buy
3,808
+1,762
+86% +$97.3K 0.02% 969
2021
Q1
$141K Buy
+2,046
New +$172K 0.01% 1203
2020
Q4
Sell
-2,078
Closed -$131K 1492
2020
Q3
$131K Buy
2,078
+1,292
+164% +$98.2K 0.02% 676
2020
Q2
$57K Buy
+786
New +$47.8K 0.01% 987
2019
Q3
Sell
-158
Closed -$34K 1477
2019
Q2
$34K Buy
+158
New +$42.6K ﹤0.01% 1291
2019
Q1
Sell
-245
Closed -$37K 1469
2018
Q4
$37K Buy
245
+208
+562% +$70.9K ﹤0.01% 1308
2018
Q3
$18K Sell
37
-11
-23% -$5.12K ﹤0.01% 1417
2018
Q2
$25K Buy
48
+25
+109% +$14.8K ﹤0.01% 1835
2018
Q1
$14K Sell
23
-36
-61% -$31.2K ﹤0.01% 1843
2017
Q4
$79K Buy
59
+7
+13% +$11.3K ﹤0.01% 1976
2017
Q3
$97K Buy
+52
New +$108K ﹤0.01% 2087

Other funds holding CRVO

Virtu Financial's CRVO Position: Q2 2026 in Review

Virtu Financial opened a new position in CervoMed (CRVO) in Q2 2026: 24,093 shares worth $75K. The stake represents ﹤0.01% of the portfolio and ranks #1157 among its holdings. This is a return to the name: Virtu Financial previously reported a position in CRVO as recently as Q4 2024.

Virtu Financial first reported a position in CRVO in Q3 2017 and has held it in 14 quarters since. The position peaked at $209K in Q2 2021. 37 funds tracked by Wall St. Rank hold CRVO as of Q2 2026.

  • Virtu Financial held 24,093 shares of CervoMed worth $75K as of Q2 2026.
  • CervoMed was a new Virtu Financial position in Q2 2026.
  • CervoMed made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1157 holding.
  • Virtu Financial first reported a position in CervoMed in Q3 2017 and has held it in 14 quarters since.
  • Virtu Financial's CervoMed position peaked at $209K in Q2 2021.
  • 37 funds tracked by Wall St. Rank held CervoMed as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.